drugset / Trial / NCT01442545
A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of JNJ-39758979 on the pharmacokinetics (how the body handles a drug) of methotrexate in participants with rheumatoid arthritis.
Timeline
- Start
- 2011-08
- Primary completion
- —
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-39758979 | Small molecule | 300 mg | Oral |
| Subject | Methotrexate | Small molecule | 7.5 mg | Oral |
| Subject | Methotrexate | Small molecule | 25 mg | Oral |